LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 14 of 483
Next
>>
>
326 to 350 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Withaferin A	0.04	uM	LJP6	2	G18	72	hr	1334	4075	3970	1.0262	1.0395
BT-20	Withaferin A	0.04	uM	LJP6	3	G18	72	hr	1334	3932	3970	0.9902	0.9852
BT-20	WYE-125132	0.04	uM	LJP6	1	L12	72	hr	1334	2968	3970	0.7474	0.6196
BT-20	WYE-125132	0.04	uM	LJP6	2	L12	72	hr	1334	3014	3970	0.7590	0.6370
BT-20	WYE-125132	0.04	uM	LJP6	3	L12	72	hr	1334	2809	3970	0.7074	0.5593
BT-20	WZ3105	0.04	uM	LJP5	1	D24	72	hr	1334	1267	3970	0.3191	-0.0257
BT-20	WZ3105	0.04	uM	LJP5	2	D24	72	hr	1334	1500	3970	0.3778	0.0627
BT-20	WZ3105	0.04	uM	LJP5	3	D24	72	hr	1334	1743	3970	0.4389	0.1549
BT-20	XMD11-50	0.04	uM	LJP6	1	P12	72	hr	1334	4142	3970	1.0431	1.0649
BT-20	XMD11-50	0.04	uM	LJP6	2	P12	72	hr	1334	3886	3970	0.9786	0.9678
BT-20	XMD11-50	0.04	uM	LJP6	3	P12	72	hr	1334	3702	3970	0.9323	0.8980
BT-20	Y39983	0.04	uM	LJP6	1	P06	72	hr	1334	4477	3970	1.1274	1.1920
BT-20	Y39983	0.04	uM	LJP6	2	P06	72	hr	1334	4005	3970	1.0086	1.0129
BT-20	Y39983	0.04	uM	LJP6	3	P06	72	hr	1334	3809	3970	0.9592	0.9386
BT-20	YM 201636	0.04	uM	LJP5	1	N12	72	hr	1334	4294	3970	1.0814	1.1226
BT-20	YM 201636	0.04	uM	LJP5	2	N12	72	hr	1334	3894	3970	0.9806	0.9708
BT-20	YM 201636	0.04	uM	LJP5	3	N12	72	hr	1334	4345	3970	1.0942	1.1419
BT-20	ZSTK474	0.04	uM	LJP6	1	M18	72	hr	1334	4328	3970	1.0899	1.1355
BT-20	ZSTK474	0.04	uM	LJP6	2	M18	72	hr	1334	3535	3970	0.8902	0.8347
BT-20	ZSTK474	0.04	uM	LJP6	3	M18	72	hr	1334	3672	3970	0.9247	0.8866
BT-20	Afatinib	0.12	uM	LJP6	1	G23	72	hr	1334	3258	3970	0.8205	0.7296
BT-20	Afatinib	0.12	uM	LJP6	2	G23	72	hr	1334	3136	3970	0.7897	0.6833
BT-20	Afatinib	0.12	uM	LJP6	3	G23	72	hr	1334	3349	3970	0.8434	0.7641
BT-20	Sigma A6730	0.12	uM	LJP5	1	B23	72	hr	1334	3194	3970	0.8044	0.7053
BT-20	Sigma A6730	0.12	uM	LJP5	2	B23	72	hr	1334	3543	3970	0.8922	0.8377

|<
<<
Previous
Page 14 of 483
Next
>>
>
326 to 350 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)